[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-358823-105":59,"doc-detail-358823-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","integrating-single-cell-and-rna-sequencing-to-predict-glioma-prognosis-through-lactylation","Integrating Single-Cell and RNA Sequencing to Predict Glioma Prognosis Through Lactylation","","Gliomas are the most prevalent primary malignant tumors of the central nervous system, characterized by frequent recurrence and poor prognosis. Tumor aerobic glycolysis elevates lactate, which drives lactylation, a post-translational modification implicated in glioma initiation and progression. This work integrates single-cell and bulk RNA-seq data to identify lactylation-enriched populations, build a LASSO-Cox risk model, and validate it across CGGA cohorts, then develop and externally validate a clinical nomogram.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrating-single-cell-and-rna-sequencing-to-predict-glioma-prognosis-through-lactylation/358823/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrating-single-cell-and-rna-sequencing-to-predict-glioma-prognosis-through-lactylation/358823.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of the study?","Question",{"text":112,"@type":113},"To integrate single-cell and bulk RNA-seq data and establish a lactylation-related gene signature that predicts glioma prognosis and improves clinical risk stratification.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is the prognostic risk model constructed and validated?",{"text":117,"@type":113},"The study develops a risk model using univariate Cox regression and LASSO, then validates predictive performance using independent cohorts from CGGA and further evaluates a nomogram with clinical variables.",{"name":119,"@type":110,"acceptedAnswer":120},"What does the risk stratification reveal about tumor biology and treatment relevance?",{"text":121,"@type":113},"Risk groups show distinct immune microenvironment profiles and different drug sensitivity patterns, supporting the model’s potential to inform drug selection and more precise, personalized therapy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},358823,1790193501,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Article  \nIntegrating Single-Cell and RNA Sequencing to Predict Glioma Prognosis Through Lactylation  \nRuyi Shen 1, Yinan Chen 1, Yan Li 2,3,* and Zhijie Lin 1,3,4, *  \nAcademic Editors: Ilias P. Nikas, Ioannis Pateras and Apostolos Zaravinos  \nReceived: 1 December 2025  \nRevised: 31 January 2026  \nAccepted: 5 February 2026  \nPublished: 8 February 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 The First Clinical Medical College, Faculty of Medicine, Yangzhou University, Yangzhou 225009, China; [222703116@stu.yzu.edu.cn](222703116@stu.yzu.edu.cn) (R.S.); [222201204@stu.yzu.edu.cn](222201204@stu.yzu.edu.cn) (Y.C.)  \n2 School of Traditional Chinese Medicine, Faculty of Medicine, Yangzhou University, Yangzhou 225009, China  \n3 Key Laboratory of the Jiangsu Higher Education Institutions for Integrated Traditional Chinese and Western Medicine in Senile Diseases Control, Yangzhou University, Yangzhou 225009, China  \n4 Department of Immunology, Faculty of Medicine, Yangzhou University, Yangzhou 225009, China  \n* Correspondence: [liyanzg@yzu.edu.cn](liyanzg@yzu.edu.cn) (Y.L.); [zjielin@yzu.edu.cn](zjielin@yzu.edu.cn) (Z.L.)  \nAbstract  \nGliomas are the most prevalent primary malignant neoplasms of the central nervous system, distinguished by their high recurrence rates and poor prognosis. Aerobic glycolysis in tumors generates excess lactate, which promotes lactylation, a post-translational modification (PTM) . Although accumulating evidence implicates lactylation in glioma initiation and progression, previous lactylation-focused prognostic studies lacked single-cell resolution and broad validation, limiting their generalizability and clinical relevance. Single-cell and bulk RNA sequencing (RNA-seq) data were integrated to identify lactylation-enriched tumor cell populations and derive candidate genes. A risk model was developed using univariate Cox regression and the Least Absolute Shrinkage and Selection Operator (LASSO), and its predictive performance was validated in independent cohorts from the China Glioma Genome Atlas (CGGA) . To improve clinical applicability, a nomogram integrating the risk score incorporating key clinical variables was constructed and externally validated. The risk groups showed distinct immune microenvironment profiles and differential drug sensitivity patterns. In this study, we established and validated a lactylation-related gene signature, with the derived risk score serving as a reliable prognostic biomarker for glioma. Furthermore, the model not only predicts overall survival (OS) but also exhibits the potential to inform drug selection and stratify patients for more precise and personalized therapeutic interventions.  \nKeywords: glioma; lactylation; prognostic model; therapy  \n1. Introduction  \nGliomas are the most common primary malignant tumors of the central nervous system and are among the most aggressive. Their diffuse, infiltrative growth typically limits surgery to maximal safe resection rather than complete removal. Moreover, the blood–brain barrier restricts delivery of many therapeutic agents, contributing to frequent recurrence and persistently poor outcomes [1,2] .  \nGlioblastoma (GBM), the most malignant subtype, progresses rapidly, recurs frequently, and exhibits intrinsic resistance to standard therapies. Despite advances in surgery, radiotherapy, and chemotherapy, these interventions rarely overcome the biological barriers posed by GBM. Consequently, GBM remains exceptionally lethal, and substantial improvements in overall survival (OS) have been limited [3] .  \nLower-grade gliomas (LGGs) grow more slowly and are generally associated with better outcomes, but they are not benign. They frequently recur and can progress to highergrade, more aggressive gliomas over time [4] . Accordingly, management often aims to delay malig","cbCainTuZkk8hBa8","https://ap.wps.com/l/cbCainTuZkk8hBa8","pdf",11154306,25,"English","# Abstract\n# Introduction","[{\"question\":\"What is the main goal of the study?\",\"answer\":\"To integrate single-cell and bulk RNA-seq data and establish a lactylation-related gene signature that predicts glioma prognosis and improves clinical risk stratification.\"},{\"question\":\"How is the prognostic risk model constructed and validated?\",\"answer\":\"The study develops a risk model using univariate Cox regression and LASSO, then validates predictive performance using independent cohorts from CGGA and further evaluates a nomogram with clinical variables.\"},{\"question\":\"What does the risk stratification reveal about tumor biology and treatment relevance?\",\"answer\":\"Risk groups show distinct immune microenvironment profiles and different drug sensitivity patterns, supporting the model’s potential to inform drug selection and more precise, personalized therapy.\"}]","Integrating Single-Cell and RNA Sequencing to Predict Glioma Prognosis Through Lactylation | PDF",1790135408,63,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e0af336bc48a437fd16b231f55c6953.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/57b983341fc7d6c6f81aa4912856fb88.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e4b77ecc783cf6387c844a33154f7f0b.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f740815885326e6b6a0b10bf8d08c4ae.webp",980,1385]